Filing Flows › Precigen (PGEN) › Q3 2026 › vs Q3 2025
Precigen (PGEN) Q3 2026 vs Q3 2025 (year over year)
Precigen's revenue rose $71.2M (25×) from $2.9M in Q3 2025 to $74.1M in Q3 2026. The biggest changes: Product revenues, net +$72.8M (450×); Service revenues +$247K (+26%).
Precigen, Q3 2026: revenue $74.1M (25× year over year), operating margin 52.1%, net earnings $35.8M, operating cash flow $11.9M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Product revenues, net | $73.0M | $162K | $72.8M | 450× |
| Service revenues | $1.2M | $942K | $247K | +26% |
| Revenue | $74.1M | $2.9M | $71.2M | 25× |
| Operating profit | $38.6M | −$34.5M | $73.1M | — |
| Costs & expenses | $35.5M | $37.4M | −$1.9M | -5% |
| Pre-tax earnings | $36.0M | −$146M | $182M | — |
| Other expense, net | $2.7M | $112M | −$109M | -98% |
| Research & development | $6.6M | $12.4M | −$5.7M | -46% |
| SG&A | $22.4M | $24.0M | −$1.6M | -7% |
| Other operating costs | $6.5M | $1.0M | $5.5M | +529% |
| Net earnings | $35.8M | −$146M | $182M | — |
| Income tax | $200K | $0 | $200K | — |
| Depreciation & amortization | $1.1M | $803K | $308K | +38% |
| Share-based compensation | $3.8M | $4.4M | −$611K | -14% |
| Working capital & other | $28.8M | −$112M | $141M | — |
| Operating cash flow | $11.9M | −$29.1M | $41.0M | — |
| Free cash flow (OCF − capex) | $11.4M | −$29.5M | $40.9M | — |
| Capital expenditures | $435K | $389K | $46K | +12% |
Questions
How much did Precigen's revenue grow year over year in Q3 2026?
Precigen's revenue rose $71.2M (25×) from $2.9M in Q3 2025 to $74.1M in Q3 2026.
What drove Precigen's revenue change in Q3 2026?
Product revenues, net +$72.8M (450×); Service revenues +$247K (+26%).